These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 18272623)

  • 21. The impact of cytology screening and HPV vaccination on the burden of cervical cancer.
    Tay K; Tay SK
    Asia Pac J Clin Oncol; 2011 Jun; 7(2):154-9. PubMed ID: 21585695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparable strategies needed to evaluate human papillomavirus vaccine efficiency across Europe.
    Soldan K; Dillner J
    Euro Surveill; 2006 Nov; 11(11):E061123.3. PubMed ID: 17213557
    [No Abstract]   [Full Text] [Related]  

  • 23. Cost-effectiveness and value-based prices of the 9-valent human papillomavirus vaccine for the prevention of cervical cancer in China: an economic modelling analysis.
    Jiang Y; Ni W; Wu J
    BMJ Open; 2019 Nov; 9(11):e031186. PubMed ID: 31767588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health economic analysis of human papillomavirus vaccines in women of Chile: perspective of the health care payer using a Markov model.
    Gomez JA; Lepetic A; Demarteau N
    BMC Public Health; 2014 Nov; 14():1222. PubMed ID: 25424716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cervical cancer: the second-generation vaccines move forward.
    Tuma RS
    J Natl Cancer Inst; 2009 Jun; 101(11):774-5. PubMed ID: 19470948
    [No Abstract]   [Full Text] [Related]  

  • 26. Development of a theory-guided storytelling narrative intervention to improve HPV vaccination behavior: Save our daughters from cervical cancer.
    Lee H; Kim M; Allison J; Kiang P
    Appl Nurs Res; 2017 Apr; 34():57-61. PubMed ID: 28342625
    [No Abstract]   [Full Text] [Related]  

  • 27. The new HPV vaccination.
    Bedford H
    Community Pract; 2008 Aug; 81(8):36-7. PubMed ID: 18834017
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recommendations for the definition of a policy on vaccination against papillomavirus in Mexico. Strategic Advisory Group of Experts of the World Health Organization].
    Lazcano-Ponce E; Salmerón-Castro J; García-Carrancá A; Aranda-Flores C; Madrid-Marina V; Gómez-Altamirano CM; Martínez-Montañez OG
    Salud Publica Mex; 2009; 51(4):336-41. PubMed ID: 19668929
    [No Abstract]   [Full Text] [Related]  

  • 29. Efficacy data and HPV vaccination studies.
    Baylor NW; Wharton M
    JAMA; 2009 Dec; 302(24):2658-9; author reply 2659-60. PubMed ID: 20040548
    [No Abstract]   [Full Text] [Related]  

  • 30. HPV, cervical cancer, and you.
    J Midwifery Womens Health; 2008; 53(3):263-264. PubMed ID: 18672495
    [No Abstract]   [Full Text] [Related]  

  • 31. Quadrivalent human papillomavirus vaccine.
    Barr E; Tamms G
    Clin Infect Dis; 2007 Sep; 45(5):609-7. PubMed ID: 17682997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based study.
    Cody P; Tobe K; Abe M; Elbasha EH
    BMC Infect Dis; 2021 Jan; 21(1):11. PubMed ID: 33407188
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prophylactic HPV vaccination for the prevention of cervical cancer.
    Hernandez BY
    Hawaii Med J; 2007 Jul; 66(7):190-1. PubMed ID: 17879858
    [No Abstract]   [Full Text] [Related]  

  • 34. Epidemiology and prevention of Human Papillomavirus.
    Manini I; Montomoli E
    Ann Ig; 2018; 30(4 Supple 1):28-32. PubMed ID: 30062377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "What school nurses need to know about cervical cancer, HPV, and the new vaccine".
    Ramirez-Odell H
    J Sch Nurs; 2008 Jun; 24(3):172. PubMed ID: 18557678
    [No Abstract]   [Full Text] [Related]  

  • 36. The known unknowns of HPV natural history.
    Gravitt PE
    J Clin Invest; 2011 Dec; 121(12):4593-9. PubMed ID: 22133884
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interim statement on HPV immunization.
    Davis DB; Lalonde AB
    J Obstet Gynaecol Can; 2007 Jan; 29(1):61, 62. PubMed ID: 17346478
    [No Abstract]   [Full Text] [Related]  

  • 38. Cervical cancers after human papillomavirus vaccination.
    Beller U; Abu-Rustum NR
    Obstet Gynecol; 2009 Feb; 113(2 Pt 2):550-552. PubMed ID: 19155953
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Eradication of cervical cancer in Latin America.
    Bosch FX
    Salud Publica Mex; 2016 Apr; 58(2):97-100. PubMed ID: 27557367
    [No Abstract]   [Full Text] [Related]  

  • 40. [Methodological aspects of clinical and economic impact of vaccine interventions and HTA. Focus on HPV vaccination].
    Ricciardi W; Dirodi B; Bonanni P; Capri S; Castiglia P; Gabutti G; Gasparini R; Giorgi Rossi P; Grilli G; La Torre G
    Ann Ig; 2011; 23(5):419-34. PubMed ID: 22403995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.